Ali AlBahar: The Immunologic Complexity Behind ABO Blood Grouping
Ali AlBahar, Transfusion Medicine Specialist, Hematology and Blood Transfusion Researcher (MSc) at Ministry of Health Saudi Arabia, shared a post on LinkedIn:
“The ABO system is more than just A, B, AB, or O.
Under the microscope, most red cells may look identical…
but immunologically, they can be completely different.
The presence or absence of ABO antigens plays a critical role in:
- Transfusion compatibility
- Immune recognition
- Patient safety
- Hemolytic risk
An ABO-incompatible transfusion is not simply a ‘blood group mismatch’ —
it can trigger a rapid, severe, and potentially fatal hemolytic transfusion reaction.
Even patients with the same ABO group may still require antibody screening and crossmatching, especially if they have a history of transfusion, pregnancy, or unexpected antibodies.
Safe transfusion starts with understanding ABO…
and is completed by proper compatibility testing.”
Stay updated with Hemostasis Today.
-
Oct 18, 2026, 00:33Elad Asher: Does Opening the Clot Change How a Patient Feels Three Months Later?
-
Oct 18, 2026, 00:22Richa Sharma: Evaluating Heterogeneity in Anticoagulation Treatment Effects in Cryptogenic Stroke
-
Oct 18, 2026, 00:07Irem Karaman Sebin: The Evidence Favoring Warfarin in High-Risk Antiphospholipid Syndrome
-
Oct 18, 2026, 00:07Emma Stevens: Lighting Up Buildings in Red and Blue for World Thrombosis Day
-
Oct 17, 2026, 23:18Maha Othman: Establishing ISTH-BAT Reference Ranges for Children and Adolescents
-
Oct 17, 2026, 17:27John Strouse: Building Standards for Whole-Person Sickle Cell Care Through Collaboration
-
Oct 17, 2026, 17:20Jean-Jacques Kiladjian: Exploring the Future of Polycythemia Vera Treatment at MPN Horizons 2026
-
Oct 17, 2026, 17:10Habib Bennaceur: Strengthening Collaboration in Haemophilia, Sickle Cell Disease and Thalassaemia in India
-
Oct 17, 2026, 16:58Danny Hsu: Building Connections at the AUSNBled Collaborative Dinner in Auckland